IS4976A - 7a-(z-Amínóakýl)estratríen, aðferð til að búa þautil, lyfjasamsetningar sem innihalda fyrrnefnd 7a-(z-amínóakýl)estratríen og notkun þeirra í framleiðslu læknislyfja - Google Patents
7a-(z-Amínóakýl)estratríen, aðferð til að búa þautil, lyfjasamsetningar sem innihalda fyrrnefnd 7a-(z-amínóakýl)estratríen og notkun þeirra í framleiðslu læknislyfjaInfo
- Publication number
- IS4976A IS4976A IS4976A IS4976A IS4976A IS 4976 A IS4976 A IS 4976A IS 4976 A IS4976 A IS 4976A IS 4976 A IS4976 A IS 4976A IS 4976 A IS4976 A IS 4976A
- Authority
- IS
- Iceland
- Prior art keywords
- estratrine
- aminoacyl
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19635525A DE19635525A1 (de) | 1996-08-20 | 1996-08-20 | 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
PCT/EP1997/004517 WO1998007740A1 (de) | 1996-08-20 | 1997-08-20 | 7α-(κ-AMINOALKYL)-ESTRATRIENE, VERFAHREN ZU DEREN HERSTELLUNG, PHARMAZEUTISCHE PRÄPARATE, DIE DIESE 7α-(κ-AMINOALKYL)-ESTRATRIENE ENTHALTEN SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN |
Publications (1)
Publication Number | Publication Date |
---|---|
IS4976A true IS4976A (is) | 1999-02-11 |
Family
ID=7804367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS4976A IS4976A (is) | 1996-08-20 | 1999-02-11 | 7a-(z-Amínóakýl)estratríen, aðferð til að búa þautil, lyfjasamsetningar sem innihalda fyrrnefnd 7a-(z-amínóakýl)estratríen og notkun þeirra í framleiðslu læknislyfja |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0920441B1 (is) |
JP (1) | JP2001503024A (is) |
KR (1) | KR20000068261A (is) |
CN (1) | CN1231670A (is) |
AR (1) | AR009278A1 (is) |
AT (1) | ATE231882T1 (is) |
AU (1) | AU728843B2 (is) |
BG (1) | BG62972B1 (is) |
BR (1) | BR9711328A (is) |
CA (1) | CA2263708A1 (is) |
CZ (1) | CZ57999A3 (is) |
DE (2) | DE19635525A1 (is) |
DK (1) | DK0920441T3 (is) |
EA (1) | EA001577B1 (is) |
EE (1) | EE04021B1 (is) |
ES (1) | ES2191857T3 (is) |
HU (1) | HUP9903106A3 (is) |
IL (1) | IL128601A (is) |
IS (1) | IS4976A (is) |
NO (1) | NO315655B1 (is) |
NZ (1) | NZ334277A (is) |
PL (1) | PL186309B1 (is) |
PT (1) | PT920441E (is) |
SK (1) | SK18899A3 (is) |
TR (1) | TR199900432T2 (is) |
TW (1) | TW552267B (is) |
UA (1) | UA50792C2 (is) |
WO (1) | WO1998007740A1 (is) |
ZA (1) | ZA977482B (is) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20000129A1 (es) * | 1997-12-23 | 2000-03-11 | Schering Ag | 11 beta-halogeno-estratrienos sustituidos en 7 alfa, asi como el procedimiento para elaborar preparados farmaceuticos que contienen tales 11 beta-halogeno-estratrienos sustituidos en 7 alfa |
US6503896B1 (en) | 1997-12-24 | 2003-01-07 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
US6548491B2 (en) | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
US6054446A (en) * | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
DE19807791A1 (de) * | 1998-02-19 | 1999-08-26 | Schering Ag | Kombinationspräparat aus Östrogen und Antiöstrogen |
DE19833786A1 (de) * | 1998-07-18 | 2000-01-20 | Schering Ag | Benzocycloheptene, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
DE19842123C1 (de) * | 1998-09-05 | 2000-07-13 | Schering Ag | 11beta-Fluor-7alpha-(14,14,15,15,15-pentafluor-6- methyl-10-thia-6-azapentadecyl)estra-1,3,5(10)- trien-3,17beta-diol als kristallines Ansolvat |
DE19906159A1 (de) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-Hydroxyestratriene als selektiv wirksame Estrogene |
EP1204657A1 (en) * | 1999-08-18 | 2002-05-15 | Schering Aktiengesellschaft | Piperidine and pyrrolidine derivatives displaying neuronal activity |
GB0000313D0 (en) * | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
DE10019171A1 (de) * | 2000-04-07 | 2001-10-18 | Schering Ag | Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe |
DE10159217A1 (de) | 2001-11-27 | 2003-06-05 | Schering Ag | 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate |
AU2006202187B2 (en) * | 2001-11-27 | 2008-11-06 | Bayer Schering Pharma Aktiengesellschaft | 17alpah-alkyl-17beta-oxy-estratrienes and intermediate products for their production, uses thereof and pharmaceutical preparations |
US20040242551A1 (en) * | 2003-05-28 | 2004-12-02 | Schering Ag | Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
US7790910B2 (en) | 2004-07-27 | 2010-09-07 | Sicor Inc. | Process for the preparation of 7α-alkylated 19-norsteroids |
US8017656B2 (en) | 2005-11-22 | 2011-09-13 | Sumitomo Chemical Company, Limited | Organic sulfur compounds and use thereof |
DE102007023614A1 (de) | 2007-05-21 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102007049630A1 (de) | 2007-10-11 | 2009-10-29 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
TW200904329A (en) | 2007-05-18 | 2009-02-01 | Sumitomo Chemical Co | Organic sulfur compound and its use for controlling harmful arthropod |
JP2009001551A (ja) | 2007-05-18 | 2009-01-08 | Sumitomo Chemical Co Ltd | 有機硫黄化合物及びその有害節足動物防除用途 |
JP5298631B2 (ja) | 2007-05-18 | 2013-09-25 | 住友化学株式会社 | 有機硫黄化合物及びその有害節足動物防除用途 |
DE102007032800A1 (de) | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
MX2010004195A (es) | 2007-10-16 | 2010-06-02 | Repros Therapeutics Inc | Trans-clomifeno para el sindrome metabolico. |
DE102007058747A1 (de) | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
EP2070941A1 (en) | 2007-12-14 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Stereoselective synthesis of selective estrogen receptor down-regulators |
EP2070909A1 (de) | 2007-12-15 | 2009-06-17 | Bayer Schering Pharma AG | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102008057230A1 (de) | 2008-11-11 | 2010-05-12 | Bayer Schering Pharma Aktiengesellschaft | Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin |
JP5212350B2 (ja) * | 2008-12-24 | 2013-06-19 | 住友化学株式会社 | 含ハロゲン有機硫黄化合物およびその用途 |
EP2258375A1 (de) | 2009-06-04 | 2010-12-08 | Bayer Schering Pharma Aktiengesellschaft | 17B-alkyl-17alpha-oxy-estratriene |
DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102009034362A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034525A1 (de) | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
WO2011092127A1 (en) | 2010-01-26 | 2011-08-04 | Bayer Schering Pharma Aktiengesellschaft | 14,17-bridged estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
US11576891B2 (en) | 2010-06-16 | 2023-02-14 | Endorecherche, Inc. | Methods of treating or preventing estrogen-related diseases |
DE102010030538A1 (de) | 2010-06-25 | 2011-12-29 | Bayer Schering Pharma Aktiengesellschaft | 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
DE102011004899A1 (de) | 2011-03-01 | 2012-09-06 | Bayer Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102011087987A1 (de) | 2011-12-08 | 2013-06-13 | Bayer Intellectual Property Gmbh | 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
EP2819676B1 (en) | 2012-02-29 | 2018-05-30 | Repros Therapeutics Inc. | Combination therapy for treating androgen deficiency |
PT3461834T (pt) | 2013-03-13 | 2021-09-10 | Sage Therapeutics Inc | Esteroides neuroativos |
SG11201507935TA (en) | 2013-04-11 | 2015-10-29 | Bayer Pharma AG | Progesterone receptor antagonist dosage form |
AU2013386732B2 (en) * | 2013-04-18 | 2018-10-18 | Xi'an Libang Pharmaceutical Technology Co., Ltd. | Ester derivative of 7-alpha-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17beta-diol having antitumour activity and preparation method thereof |
JP7048505B2 (ja) | 2015-11-10 | 2022-04-05 | パラクリン セラピューティクス エービー | Pdgf-cc阻害剤および抗エストロゲン剤によるer陰性乳癌の処置 |
CA3019146C (en) | 2016-04-01 | 2024-03-26 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
WO2017193046A1 (en) | 2016-05-06 | 2017-11-09 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
RS62222B1 (sr) | 2016-07-07 | 2021-09-30 | Sage Therapeutics Inc | 24-hidroksisteroli supstituisani na poziciji 11 za upotrebu u lečenju stanja povezanih sa nmda |
CN110023323A (zh) | 2016-09-30 | 2019-07-16 | 萨奇治疗股份有限公司 | C7取代的氧固醇及其作为nmda调节剂的方法 |
MX2019004679A (es) | 2016-10-18 | 2019-10-15 | Sage Therapeutics Inc | Oxisteroles y metodos de uso de los mismos. |
CN115505019B (zh) * | 2022-11-07 | 2024-01-26 | 南宁师范大学 | 7-酰胺取代雌甾类化合物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8327256D0 (en) * | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
HU208150B (en) * | 1988-10-31 | 1993-08-30 | Endorecherche Inc | Process for producing new estrogen derivatives having steroid hormone inhibitor activity and pharmaceutical compositions comprising such derivatives |
DE3925507A1 (de) * | 1989-07-28 | 1991-01-31 | Schering Ag | 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln |
DE4218743C2 (de) * | 1992-06-04 | 2001-10-25 | Schering Ag | Verfahren zur Herstellung C(7)-substituierter Estra-1,3,5(10)-triene sowie neue Ausgangsprodukte für dieses Verfahren |
-
1996
- 1996-08-20 DE DE19635525A patent/DE19635525A1/de not_active Withdrawn
-
1997
- 1997-08-20 CA CA002263708A patent/CA2263708A1/en not_active Abandoned
- 1997-08-20 KR KR1019997001396A patent/KR20000068261A/ko not_active Application Discontinuation
- 1997-08-20 HU HU9903106A patent/HUP9903106A3/hu unknown
- 1997-08-20 PL PL97331863A patent/PL186309B1/pl not_active IP Right Cessation
- 1997-08-20 WO PCT/EP1997/004517 patent/WO1998007740A1/de not_active Application Discontinuation
- 1997-08-20 AR ARP970103779A patent/AR009278A1/es not_active Application Discontinuation
- 1997-08-20 DE DE59709239T patent/DE59709239D1/de not_active Expired - Fee Related
- 1997-08-20 CZ CZ99579A patent/CZ57999A3/cs unknown
- 1997-08-20 NZ NZ334277A patent/NZ334277A/xx unknown
- 1997-08-20 ZA ZA9707482A patent/ZA977482B/xx unknown
- 1997-08-20 EA EA199900210A patent/EA001577B1/ru not_active IP Right Cessation
- 1997-08-20 SK SK188-99A patent/SK18899A3/sk unknown
- 1997-08-20 CN CN97198245A patent/CN1231670A/zh active Pending
- 1997-08-20 TR TR1999/00432T patent/TR199900432T2/xx unknown
- 1997-08-20 PT PT97943814T patent/PT920441E/pt unknown
- 1997-08-20 AT AT97943814T patent/ATE231882T1/de not_active IP Right Cessation
- 1997-08-20 DK DK97943814T patent/DK0920441T3/da active
- 1997-08-20 IL IL12860197A patent/IL128601A/xx not_active IP Right Cessation
- 1997-08-20 TW TW086111927A patent/TW552267B/zh active
- 1997-08-20 ES ES97943814T patent/ES2191857T3/es not_active Expired - Lifetime
- 1997-08-20 AU AU45520/97A patent/AU728843B2/en not_active Ceased
- 1997-08-20 BR BR9711328A patent/BR9711328A/pt unknown
- 1997-08-20 EE EEP199900075A patent/EE04021B1/xx not_active IP Right Cessation
- 1997-08-20 EP EP97943814A patent/EP0920441B1/de not_active Expired - Lifetime
- 1997-08-20 UA UA99031552A patent/UA50792C2/uk unknown
- 1997-08-20 JP JP10510412A patent/JP2001503024A/ja not_active Ceased
-
1999
- 1999-02-11 IS IS4976A patent/IS4976A/is unknown
- 1999-02-16 BG BG103185A patent/BG62972B1/bg unknown
- 1999-02-19 NO NO19990793A patent/NO315655B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4976A (is) | 7a-(z-Amínóakýl)estratríen, aðferð til að búa þautil, lyfjasamsetningar sem innihalda fyrrnefnd 7a-(z-amínóakýl)estratríen og notkun þeirra í framleiðslu læknislyfja | |
IS2156B (is) | Settar bensensúlfonamíðafleiður sem forlyf fyrir COX-2 tálma, aðferð til þess að búa þær til, lyfjasamsetningar sem innihalda þær og notkun þeirra við framleiðslu lyfja | |
HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
HUP0300618A3 (en) | Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0001652A3 (en) | Oxadiazole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them | |
IS4839A (is) | Nýjar bensazepín afleiður, læknislyf sem innihalda þær og notkun þeirra við að útbúa læknislyf | |
EE9700145A (et) | Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid | |
HUP9700358A3 (en) | New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0203548A3 (en) | New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
IS5526A (is) | 11ß-Halógen-7alfa-setin estratríen, aðferð til framleiðslu á lyfjasamsetningum sem innihalda fyrrnefnd estratríen og notkun þeirra til framleiðslu á læknislyfjum | |
HUP0300616A3 (en) | Adamantane derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0103851A3 (en) | Factor viia inhibitors, process for their preparation, their use and pharmaceutical compositions comprising thereof | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
HUP9801044A3 (en) | Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
EE04463B1 (et) | 3-arüülpropaanhappe derivaadid ja nende analoogid, nende valmistamise meetod, neid sisaldavad ravimkoostised ja ühendid kasutamiseks ravis | |
HUP9801045A3 (en) | Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation | |
HUP0203052A3 (en) | Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0002404A3 (en) | Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use | |
HUP0102602A3 (en) | Diacylhydrazine derivatives, method for their preparation, their use and pharmaceutical compositions comprising thereof | |
HUP0000664A3 (en) | Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions | |
PL344246A1 (en) | Novel pharmaceutical composition for use in emergency treatment and preparation method thereof | |
IL126271A0 (en) | 2-Arylpyrazolisoquinoline and cinnolinone derivatives methods for their preparation and pharmaceutical formulations containing them | |
HUP0202075A3 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0102515A3 (en) | Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
EE9900112A (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid |